Slavnova E N, Tyurina N G, Golovin S T, Petrov A N
The P.A. Hertsen Moscow research oncologic institute, the branch of the National medical radiologic research center of Minzdrav of Russia, 125284, Moscow, Russia.
The clinical hospital "The Moscow medical sanitary unit of the Interior Ministry", 127299, Moscow, Russia.
Klin Lab Diagn. 2017;62(8):490-497. doi: 10.18821/0869-2084-2017-62-8-490-497.
The purpose of study: To determine possibilities of complex morphological diagnostic (routine cytology and histology, immunocytochemistry and immunohistochemistry, molecular genetics) of lymphoma of marginal zone. The study included 10 patients with diagnosis of lymphoma of marginal zone cells, established on the basis of application of morphological (cytological and histological), immunomorphologic (immunocytochemical and immunohistochemical) and molecular genetic techniques. The immunofenotyping was implemented using immunocytochemical technique (EnVision FLEX) applying monoclonal antibodies by DAKO manufacturer. The immunofenotyping was implemented by flow cytofluorometry technique (flow cytofluorometer FACS Calibur by Becton Dikinson, USA) using antibodies by DACO manufacturer labeled by fluorescent marks (FITC or RPE). The antibody panel included: common leukocytic antigen, common cytokeratins CD19, CD20, CD79a,CD10, Bcl2, Bcl6, CD23, CD34, TdT, CD3, CD4, CD5, CD8, CyclinD1, Ki67, κ, λ. The FISH technique was applied using probes Bcl2 FISH DNA Probe, Split Signal и MALT1 FISH DNA Probe Split Signal by DAKO manufacturer. In one patient a gene Bcl2 change was detected with purpose of differentiating diagnostic with follicular lymphoma. In three patients, diagnosing lymphoma of marginal zone was implemented by FISH technique using detection of translocation (11;18)(q21;q21), involving gene of inhibitor of apoptosis API2 and gene MALT1. The routine cytological analysis of ten cases permitted to establish an exact diagnosis of lymphoma only in five cases and with no indication that it is lymphoma of marginal zone. In two cases under routine cytological analysis only a suspicion about lymphoma was suggested. In all ten patients a positive expression of pan-B-cellular markers CD19, CD20, CD79a was observed both under immunocytochemistry and immunohistochemistry and flow cytofluorometry. In 6 patients (60%) a positive expression of gene Bcl2 was observed both under immunocytochemistry and immunohistochemistry and flow cytofluorometry. The comparison of immunocytochemistry and immunohistochemistry and flow cytofluorometry established absence of expression of CD5, CD3, CD10, CD34, CD23, Bcl6, TdT, cyclin D1. Under immunocytochemistry and immunohistochemistry in ten cases proliferative activity protein Ki-67made up no more than 30%. Under flow cytofluorometry clonality on light chains of immunoglobulins κ or λ (Igλ/Igκ) were established. Overall, correlation coefficient (r, p < 0,05) between immunocytochemistry and immunohistochemistry, flow cytofluorometry made up to 1. The four patients were applied FISH-reaction for adjustment of diagnosis. In patient with nodal lymphoma of marginal zone gene Bcl2 change was absent. In three patients with MALT-lymphoma a gene MALT1 change was established. Thereby, accuracy of routine cytological analysis at diagnosing lymphoma without indication of its type in case of lymphoma of marginal zone made up to 50%, sensitivity - 50%, specificity - 100%. The accuracy of immunofenotyping permitting diagnosing lymphoma of marginal zone made up to 100%, sensitivity - 100%, specificity - 100%. The correlation coefficient (r, p < 0,05) between data of immunocytochemistry and immunohistochemistry, flow cytofluorometry made up to 1. The accuracy, sensitivity and specificity of complex analysis (cytology, immunocytochemistry and FISH-technique) in diagnostic of lymphoma of marginal zone made up to 100%.
确定边缘区淋巴瘤的综合形态学诊断(常规细胞学和组织学、免疫细胞化学和免疫组织化学、分子遗传学)的可能性。该研究纳入了10例边缘区细胞淋巴瘤患者,诊断基于形态学(细胞学和组织学)、免疫形态学(免疫细胞化学和免疫组织化学)及分子遗传学技术。免疫表型分析采用免疫细胞化学技术(EnVision FLEX),应用丹麦达科公司生产的单克隆抗体。免疫表型分析通过流式细胞荧光术(美国贝克曼库尔特公司的流式细胞荧光仪FACS Calibur)进行,使用丹麦达科公司生产的标记有荧光标记(异硫氰酸荧光素或藻红蛋白)的抗体。抗体组合包括:共同白细胞抗原、常见细胞角蛋白、CD19、CD20、CD79a、CD10、Bcl2、Bcl6、CD23、CD34、末端脱氧核苷酸转移酶、CD3、CD4、CD5、CD8、细胞周期蛋白D1、Ki67、κ、λ。采用丹麦达科公司生产的Bcl2 FISH DNA探针、分裂信号和MALT1 FISH DNA探针分裂信号进行荧光原位杂交技术检测。在1例患者中检测到Bcl2基因改变,以鉴别诊断滤泡性淋巴瘤。在3例患者中,通过荧光原位杂交技术检测到易位(11;18)(q21;q21),涉及凋亡抑制因子API2基因和MALT1基因,从而诊断为边缘区淋巴瘤。10例病例的常规细胞学分析仅在5例中确诊为淋巴瘤,且未提示为边缘区淋巴瘤。在2例常规细胞学分析中仅提示疑似淋巴瘤。在所有10例患者中,免疫细胞化学、免疫组织化学及流式细胞荧光术均观察到泛B细胞标志物CD19、CD20、CD79a呈阳性表达。在6例患者(60%)中,免疫细胞化学、免疫组织化学及流式细胞荧光术均观察到Bcl2基因呈阳性表达。免疫细胞化学与免疫组织化学及流式细胞荧光术的比较显示,CD5、CD3、CD10、CD34、CD23、Bcl6、末端脱氧核苷酸转移酶、细胞周期蛋白D1无表达。免疫细胞化学和免疫组织化学检测显示,10例病例中增殖活性蛋白Ki-67不超过30%。流式细胞荧光术检测确定了免疫球蛋白κ或λ轻链的克隆性(Igλ/Igκ)。总体而言,免疫细胞化学与免疫组织化学、流式细胞荧光术之间的相关系数(r,p<0.05)为1。4例患者应用荧光原位杂交反应调整诊断。在1例边缘区淋巴结淋巴瘤患者中未检测到Bcl2基因改变。在3例黏膜相关淋巴组织淋巴瘤患者中检测到MALT1基因改变。因此,在边缘区淋巴瘤病例中,无淋巴瘤类型提示时常规细胞学分析诊断淋巴瘤的准确性为50%,敏感性为50%,特异性为100%。免疫表型分析诊断边缘区淋巴瘤的准确性为100%,敏感性为100%,特异性为100%。免疫细胞化学与免疫组织化学、流式细胞荧光术数据之间的相关系数(r,p<0.05)为1。边缘区淋巴瘤诊断中综合分析(细胞学、免疫细胞化学和荧光原位杂交技术)的准确性、敏感性和特异性均为100%。